GR3007686T3 - - Google Patents

Info

Publication number
GR3007686T3
GR3007686T3 GR930400188T GR930400188T GR3007686T3 GR 3007686 T3 GR3007686 T3 GR 3007686T3 GR 930400188 T GR930400188 T GR 930400188T GR 930400188 T GR930400188 T GR 930400188T GR 3007686 T3 GR3007686 T3 GR 3007686T3
Authority
GR
Greece
Prior art keywords
inositoltrisphosphate
combatting
lipoproteins
isomer
medicament
Prior art date
Application number
GR930400188T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007686T3 publication Critical patent/GR3007686T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
GR930400188T 1988-09-15 1993-04-22 GR3007686T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel

Publications (1)

Publication Number Publication Date
GR3007686T3 true GR3007686T3 (enExample) 1993-08-31

Family

ID=20373330

Family Applications (4)

Application Number Title Priority Date Filing Date
GR920400982T GR3005448T3 (enExample) 1988-09-15 1992-08-20
GR920402459T GR3006825T3 (enExample) 1988-09-15 1993-01-21
GR930400188T GR3007686T3 (enExample) 1988-09-15 1993-04-22
GR940403975T GR3015764T3 (en) 1988-09-15 1995-04-13 Use of inositol triphosphate in the preparation of a medicament against diabetes.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GR920400982T GR3005448T3 (enExample) 1988-09-15 1992-08-20
GR920402459T GR3006825T3 (enExample) 1988-09-15 1993-01-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR940403975T GR3015764T3 (en) 1988-09-15 1995-04-13 Use of inositol triphosphate in the preparation of a medicament against diabetes.

Country Status (8)

Country Link
EP (5) EP0359257B1 (enExample)
JP (5) JP2859319B2 (enExample)
AT (5) ATE120958T1 (enExample)
DE (5) DE68922165T2 (enExample)
ES (5) ES2073419T3 (enExample)
GB (5) GB2223403B (enExample)
GR (4) GR3005448T3 (enExample)
SE (2) SE464059C (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
JPH04504847A (ja) * 1989-03-08 1992-08-27 ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション インスリン抵抗性糖尿病のための食事用補添物
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
SE467340B (sv) * 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE9600194D0 (sv) * 1996-01-19 1996-01-19 Perstorp Ab A new chemical compound
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
SE9601396D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US6486127B1 (en) 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
KR100653557B1 (ko) * 2001-10-06 2006-12-05 아미코젠주식회사 카이로 이노시톨 또는 피니톨의 백내장 예방치료제로서의용도와 그 조성물
JP7086980B2 (ja) * 2017-10-26 2022-06-20 大塚製薬株式会社 イノシトールリン酸含有組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel

Also Published As

Publication number Publication date
ES2054965T3 (es) 1994-08-16
EP0359257B1 (en) 1995-04-12
GB2223168B (en) 1992-08-12
JPH02191217A (ja) 1990-07-27
ES2045319T3 (es) 1994-01-16
EP0359256A2 (en) 1990-03-21
GB8920811D0 (en) 1989-11-01
EP0359258B1 (en) 1994-04-27
EP0359259B1 (en) 1992-08-19
ES2073419T3 (es) 1995-08-16
EP0359260A2 (en) 1990-03-21
ATE88347T1 (de) 1993-05-15
GB2223404B (en) 1992-04-08
ATE104855T1 (de) 1994-05-15
GB8920806D0 (en) 1989-11-01
GB8920804D0 (en) 1989-11-01
JPH02191219A (ja) 1990-07-27
JPH02191221A (ja) 1990-07-27
DE68914922D1 (de) 1994-06-01
ATE120958T1 (de) 1995-04-15
GR3006825T3 (enExample) 1993-06-30
SE8803248D0 (sv) 1988-09-15
SE8803248L (sv) 1990-03-16
DE68902526T2 (de) 1993-03-11
JPH02191218A (ja) 1990-07-27
SE9003395L (sv) 1992-04-25
EP0359259A2 (en) 1990-03-21
SE9003395D0 (sv) 1990-10-24
GR3015764T3 (en) 1995-07-31
EP0359258A3 (en) 1990-10-03
GR3005448T3 (enExample) 1993-05-24
ATE84719T1 (de) 1993-02-15
GB2223169A (en) 1990-04-04
DE68922165D1 (de) 1995-05-18
ES2043998T3 (es) 1994-01-01
DE68922165T2 (de) 1995-09-14
DE68904507D1 (de) 1993-03-04
ATE79542T1 (de) 1992-09-15
JP2859319B2 (ja) 1999-02-17
EP0359259A3 (en) 1990-10-03
GB2223167B (en) 1992-02-26
JP2547257B2 (ja) 1996-10-23
EP0359260A3 (en) 1990-10-03
GB2223403B (en) 1992-02-26
GB2223167A (en) 1990-04-04
EP0359256A3 (en) 1990-10-10
DE68902526D1 (de) 1992-09-24
EP0359258A2 (en) 1990-03-21
ES2055772T3 (es) 1994-09-01
GB2223169B (en) 1992-04-08
SE464059B (sv) 1991-03-04
GB2223404A (en) 1990-04-11
GB2223168A (en) 1990-04-04
EP0359256B1 (en) 1993-01-20
SE464059C (sv) 1997-06-02
JP2859318B2 (ja) 1999-02-17
JPH02191220A (ja) 1990-07-27
JP3058334B2 (ja) 2000-07-04
DE68904507T2 (de) 1993-06-09
GB2223403A (en) 1990-04-11
DE68906106T2 (de) 1993-10-21
EP0359257A3 (en) 1990-10-03
DE68914922T2 (de) 1994-09-01
EP0359260B1 (en) 1993-04-21
EP0359257A2 (en) 1990-03-21
GB8920805D0 (en) 1989-11-01
DE68906106D1 (de) 1993-05-27
GB8920807D0 (en) 1989-11-01

Similar Documents

Publication Publication Date Title
GR3006825T3 (enExample)
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
TW275584B (enExample)
EP0435443A3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ZA884418B (en) Pharmaceutical dosage unit
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
NZ247406A (en) Treatment of osteoporosis with 1 alpha, 24(r)-dihydroxy-22(e)-dehydro-vitamin d3
GR3018651T3 (en) Treatment of ocular hypertention with a synergistic combination